OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0581-AD54 View EO 12866 Meetings | Received Date: 01/18/2017 |
| Title: National Bioengineered Food Disclosure Standard | |
| Agency/Subagency: USDA / AMS | |
| Concluded Action: Withdrawn | Concluded Date: 01/24/2017 |
| Publication Date: | |
| Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses |
| Federalism Implications: Yes | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: Yes | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: Uncollected | |
An official website of the United States government



